Advanced imaging in neuroimmunological diseases (ImaginEM)
Featured publications
-
Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders
Guasp, Mar; Rosa-Justicia, Mireia; Munoz-Lopetegi, Amaia; Martinez-Hernandez, Eugenia; Armangue, Thais;(...)Llufriu, Sara; Sanchez-Valle, Raquel; Santamaria, Joan; Castro-Fornielest, Josefina; Dalmau, Josep.Reference:Lancet Neurology 2022.
-
Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis
Lopez-Soley, Elisabet; Martinez-Heras, Eloy; Andorra, Magi; Solanes, Aleix; Radua, Joaquim;(...)Martinez-Lapiscina, Elena H; Villoslada, Pablo; Saiz, Albert; Solana, Elisabeth; Llufriu, Sara.Reference:J Pers Med 2021.
-
Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability
Capuano, R; Zubizarreta, I; Alba-Arbalat, S; Sepulveda, M; Sola-Valls, N;(...)Villoslada, P; Saiz, A; Llufriu, S; Villar, LM; Martinez-Lapiscina, EH.Reference:Multiple Sclerosis Journal 2021.
-
Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients
Solana, Elisabeth; Martinez-Heras, Eloy; Montal, Victor; Vilaplana, Eduard; Lopez-Soley, Elisabet;(...)Martinez-Lapiscina, E H; Prados, Ferran; Saiz, Albert; Fortea, Juan; Llufriu, Sara.Reference:Scientific Reports 2021.
-
Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS Unit
Sepúlveda, M; Llufriu, S; Martínez-Hernández, E; Català, M; Artola, M;(...)Aldea, M; Prats, C; Graus, F; Blanco, Y; Saiz, A.Reference:Neurology-Neuroimmunology & Neuroinflammation 2021.
-
Retinal and brain damage during multiple sclerosis course: inflammatory activity is a key factor in the first 5 years
Pulido-Valdeolivas, I; Andorrá, M; Alba-Arbalat, S; Zubizarreta, I; Llufriu, S;(...)Gómez-Andrés, D; Nakamura, K; Lampert, EJ; Camos-Carreras, A; Sanchez-Dalmau, B.Reference:Scientific Reports 2020.
-
Characterization of multiple sclerosis lesions with distinct clinical correlates through quantitative diffusion MRI
Martinez-Heras, Eloy; Solana, Elisabeth; Prados, Ferran; Andorra, Magi; Solanes, Aleix;(...)Sepulveda, Maria; Blanco, Yolanda; Saiz, Albert; Radua, Joaquim; Llufriu, Sara.Reference:Neuroimage-Clinical 2020.
-
Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus
Sepulveda, M; Delgado-García, G; Blanco, Y; Sola-Valls, N; Martinez-Lapiscina, EH;(...)Llufriu, S; Dalmau, J; Graus, F; Saiz, A; Ruiz-García, R.Reference:Neurology-Neuroimmunology & Neuroinflammation 2019.
-
Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial
Zubizarreta, Irati; Florez-Grau, Georgina; Vila, Gemma; Cabezon, Raquel; Espana, Carolina;(...)Lozano, Miquel; Blanco, Yolanda; Steinman, Lawrence; Benitez-Ribas, Daniel; Villoslada, Pablo.Reference:Proceedings Of The National Academy Of Sciences Of The United States Of America 2019.
-
Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis.
Andorra, M; Lampert, EJ; Pulido-Valdeolivas, I; Zubizarreta, I; Llufriu, S;(...)Blanco, Y; Saiz, A; Villoslada, P; Martinez-Lapiscina, EH; Nakamura, K.Reference:Jama Neurology 2018.